Adaptive Biotechnologies ... (ADPT)
NASDAQ: ADPT
· Real-Time Price · USD
13.03
0.11 (0.85%)
At close: Aug 15, 2025, 3:59 PM
13.05
0.15%
After-hours: Aug 15, 2025, 07:25 PM EDT
Adaptive Biotechnologies Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 205.22M | 189.53M | 178.96M | 177.28M | 168.77M | 174.5M | 170.28M | 179.69M | 189.6M | 184.34M | 185.31M | 168.04M | 159.68M | 154.52M | 154.34M | 146.6M | 133.43M | 115.91M |
Cost of Revenue | 69.69M | 73.79M | 74.86M | 81.83M | 84.51M | 80.31M | 80.94M | 72.53M | 68.09M | 63.4M | 57.91M | 55.68M | 54.96M | 52.5M | 49.3M | 41.17M | 33.03M | 27.18M |
Gross Profit | 135.53M | 115.73M | 104.09M | 95.45M | 84.26M | 94.19M | 89.33M | 107.16M | 121.51M | 120.94M | 127.4M | 112.36M | 104.72M | 102.02M | 105.04M | 105.43M | 100.4M | 88.74M |
Operating Income | -121.11M | -135.51M | -154.66M | -166.47M | -184.79M | -193.18M | -201.61M | -195.15M | -189.63M | -194.31M | -200.19M | -222.6M | -233.49M | -230.75M | -208.97M | -191.61M | -172.33M | -159.48M |
Interest Income | 8.94M | 10.31M | 14.53M | 16.07M | 16.88M | 16.73M | 15.53M | 13.52M | 10M | 6.81M | 4.06M | 1.69M | 1.25M | 1.3M | 1.67M | 2.21M | 2.9M | 4.33M |
Pretax Income | -121.23M | -141.89M | -159.57M | -195.32M | -213.55M | -215.11M | -225.28M | -195.98M | -191M | -195.27M | -200.37M | -221.56M | -232.24M | -229.45M | -207.3M | -189.4M | -169.43M | -155.14M |
Net Income | -121.23M | -141.84M | -159.49M | -195.24M | -213.47M | -215.06M | -225.25M | -180.33M | -175.31M | -179.13M | -183.96M | -220.87M | -231.58M | -229.26M | -207.37M | -190.51M | -171.23M | -155.47M |
Selling & General & Admin | 159.25M | 156.09M | 157.56M | 160.57M | 163.32M | 171.29M | 172.51M | 176.03M | 177.72M | 177.03M | 184.13M | 188.03M | 190.86M | 184.66M | 169.97M | 151.87M | 133.32M | 120.61M |
Research & Development | 95.69M | 94.55M | 100.59M | 101.18M | 105.55M | 114.8M | 117.15M | 124.59M | 131.72M | 136.52M | 141.76M | 145.23M | 145.65M | 146.41M | 142.34M | 143.47M | 137.72M | 125.91M |
Other Expenses | 1.7M | 8.9M | 8.91M | 8.48M | 8.48M | 1.27M | 1.27M | 1.7M | 1.27M | 1.27M | 1.27M | 1.27M | 1.7M | 1.7M | 1.7M | 1.7M | 1.7M | 1.7M |
Operating Expenses | 256.63M | 251.24M | 258.76M | 261.92M | 269.05M | 287.36M | 290.94M | 302.32M | 311.14M | 315.25M | 327.58M | 334.96M | 338.21M | 332.77M | 314.01M | 297.04M | 272.73M | 248.21M |
Interest Expense | 11.74M | 11.49M | 11.58M | 11.64M | 12.35M | 13.26M | 13.8M | 14.37M | 11.37M | 7.77M | 4.24M | 653K | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | 88.75M | 85.49M | 84.76M | 85.09M | 85.03M | 88.59M | 88.58M | 90.39M | 91.41M | 91.82M | 95.6M | 98.58M | 102.02M | 100.95M | 95.47M | 87.31M | 76.84M | 67.95M |
Cost & Expenses | 326.32M | 325.03M | 333.62M | 343.75M | 353.56M | 367.68M | 371.88M | 374.84M | 379.23M | 378.65M | 385.49M | 390.64M | 393.17M | 385.27M | 363.31M | 338.21M | 305.76M | 275.39M |
Income Tax Expense | n/a | -26K | -26K | -52K | -5.82M | -5.79M | -5.79M | -21.41M | -15.65M | -16.1M | -16.37M | -909K | -909K | -453K | -182K | 1.12M | 1.8M | 323K |
Shares Outstanding (Basic) | 152.08M | 149.19M | 147.1M | 147.52M | 147.41M | 145.79M | 144.9M | 144.7M | 144.4M | 143.51M | 143.05M | 142.93M | 140.66M | 141.7M | 140.21M | 140.83M | 140.36M | 138.97M |
Shares Outstanding (Diluted) | 152.08M | 149.19M | 147.1M | 147.52M | 147.41M | 145.79M | 144.9M | 144.7M | 144.4M | 143.51M | 143.05M | 142.93M | 142.36M | 141.7M | 141.23M | 140.83M | 140.36M | 138.97M |
EPS (Basic) | -0.82 | -0.96 | -1.09 | -1.34 | -1.47 | -1.49 | -1.56 | -1.25 | -1.22 | -1.26 | -1.3 | -1.57 | -1.65 | -1.63 | -1.48 | -1.37 | -1.24 | -1.15 |
EPS (Diluted) | -0.82 | -0.96 | -1.09 | -1.34 | -1.47 | -1.49 | -1.56 | -1.25 | -1.22 | -1.25 | -1.29 | -1.55 | -1.63 | -1.62 | -1.47 | -1.37 | -1.24 | -1.15 |
EBITDA | -98.63M | -119.04M | -128.76M | -163.5M | -177.99M | -176.17M | -185.59M | -154.02M | -155.01M | -163.37M | -170.57M | -197.83M | -208.05M | -209.83M | -192.49M | -179.55M | -164.19M | -152.24M |
EBIT | -115.33M | -136.23M | -148.01M | -183.71M | -201.22M | -201.88M | -211.5M | -181.63M | -179.63M | -187.5M | -196.13M | -221.14M | -232.47M | -230.16M | -208.64M | -191.28M | -172.33M | -159.48M |
Depreciation & Amortization | 16.69M | 17.2M | 19.26M | 20.2M | 23.23M | 25.71M | 25.92M | 27.61M | 25.38M | 24.9M | 26.32M | 25.85M | 26.19M | 23.85M | 21.41M | 15.22M | 11.64M | 8.97M |